Suven Life Sciences Limited — Others, 22-08-2025: Shareholders meeting

Suven Life Sciences shareholders have approved all proposed resolutions at the company's 36th Annual General Meeting. Key approvals include the adoption of the audited standalone and consolidated financial statements for the financial year ended March 31, 2025. Shareholders also re-appointed Smt. Sudharani Jasti as a Director and approved the appointment of Secretarial Auditors. All resolutions passed with an overwhelming majority of votes, indicating strong shareholder confidence in the company's governance and direction.